A cocktail of recombinant multiclonal anti-melanoma antibody consisting of HMB45 and two different clones of MART-1 (M2-7C10, M2-9E3) was selected for the quantification of the viable melanoma cells in the examined tumors as well as their migration in the near proximity (Figure 8A,B). This evidence concerns the gene MLANA and melanoma.